Barclays’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-2,000
Closed -$466K – 5432
2024
Q3
$466K Sell
2,000
-2,100
-51% -$431K ﹤0.01% 3826
2024
Q2
$827K Buy
4,100
+2,000
+95% +$360K ﹤0.01% 2717
2024
Q1
$360K Hold
2,100
– – ﹤0.01% 3787
2023
Q4
$456K Buy
+2,100
New +$360K ﹤0.01% 3936
2022
Q3
– Sell
-37,600
Closed -$8.19M – 5059
2022
Q2
$8.19M Buy
+37,600
New +$8.55M 0.01% 1094

Other funds holding PODD

Barclays's PODD Position: Q3 2026 in Review

Barclays increased its Insulet (PODD) stake by 112% in Q3 2026, buying an estimated $19M and bringing the position to 240,286 shares worth $31.4M. The position accounts for 0.01% of the portfolio, ranked #1003.

Barclays first reported a position in PODD in Q2 2013 and has held it in 54 quarters since. The position peaked at $73.1M in Q1 2024. 693 funds tracked by Wall St. Rank hold PODD as of Q3 2026.

  • Barclays held 240,286 shares of Insulet worth $31.4M as of Q3 2026.
  • Barclays bought 126,814 Insulet shares in Q3 2026, an estimated $19M.
  • Insulet made up 0.01% of Barclays's portfolio in Q3 2026, its #1003 holding.
  • Barclays first reported a position in Insulet in Q2 2013 and has held it in 54 quarters since.
  • Barclays's Insulet position peaked at $73.1M in Q1 2024.
  • 693 funds tracked by Wall St. Rank held Insulet as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.